Authors' objectives: Repetitive high-frequency left transcranial magnetic stimulation (HFL-rTMS) is a noninvasive technique that may serve as an alternative intervention for treatment-resistant depression (TRD). Brief repetitive pulses of magnetic energy are applied to the scalp via a large electromagnetic coil, thereby modulating electrical current in the underlying cortical tissue. The goal of HFL-rTMS is to influence activity in areas of the brain involved in mood regulation, in order to shorten the duration or reduce the severity of depressive episodes. HFL-rTMS may be used to augment current pharmacotherapy or as a primary treatment strategy for medication-free patients. Controversy: The comparative effectiveness and safety of HFL-rTMS relative to electroconvulsive therapy (ECT), ECT combined with HFL-rTMS (ECT+HFL-rTMS), and bilateral repetitive transcranial magnetic stimulation (rTMS) in patients who have not responded to pharmacotherapy are unknown. Relevant Questions: How does HFL-rTMS compare with ECT and bilateral rTMS with regard to improvement of depression symptoms for patients with TRD? How does HFL-rTMS compare with ECT and bilateral rTMS with regard to rates of response and remission for patients with TRD? How does HFL-rTMS compare with ECT and bilateral rTMS with regard to safety for patients with TRD? Have definitive patient selection criteria been established for HFL-rTMS, ECT, and bilateral rTMS?

Project Status: Completed

Year Published: 2016

URL for published report: The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=54986

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: United States

Organisation Name: HAYES, Inc.

Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218

Contact Name: saleinfo@hayesinc.com

Contact Email: saleinfo@hayesinc.com

Copyright: 2014 Winifred S. Hayes, Inc